PUBLISHER: Grand View Research | PRODUCT CODE: 1224600
PUBLISHER: Grand View Research | PRODUCT CODE: 1224600
The global electronic data capture systems market size is anticipated to reach USD 3.63 billion by 2030, expanding at a CAGR of 14.6%, according to a new report by Grand View Research, Inc. The key factors driving the market growth include the digitalization of clinical trials, increasing R&D investments, adoption of eClinical solutions, and the need to standardize data collection and quality checks. EDC systems improve information management and analysis, accelerate the timeline for clinical trial approval, and support faster decision-making pertaining to product approval procedures. Medical device manufacturers, CROs, and biopharmaceutical companies are adopting these solutions to save the cost and time spent on clinical trial data management.
Clinical trial operations were significantly impacted due to the COVID-19 pandemic. In fact, an estimated 12% of clinical trial activity was paused according to a survey published by Oracle in 2021. However, the pandemic also catalyzed the adoption of clinical trials automation, operation, and data management technologies such as teleconsultations, EHR, remote monitoring, digital consent, and clinical data capture & management systems. Around 76% of the respondents comprising representatives from the pharma & biotech industry, the medical devices industry, and CROs reported that the COVID-19 public health emergency accelerated their usage of decentralized clinical trial methods. This is estimated to fuel the demand for EDC systems as the management of clinical trials continues to undergo digitalization post-COVID.
The associated benefits of an eClinical solution, or EDC as part of an eClinical solution, are also expected to increase the adoption of such solutions in the coming years. These include recommendations on the medical interpretation of emergent findings, the use of AI and analytics, and the elimination of data discrepancies. The other benefits of adopting EDC systems include advanced statistical analysis and improved compilation of technical & scientific data required for the fulfillment of regulatory prerequisites of clinical trials. The growing awareness pertaining to the advantages of EDC services over paper-based clinical information management is a major factor contributing to the growth of this market.
Moreover, the rising trend of outsourcing across the healthcare IT services industry creates more avenues for contract research organizations to enter into the eClinical solutions marketplace. The increasing number of decentralized clinical trials also presents lucrative opportunities for market players active in the EDC systems market. Growing adoption of cloud-based services, rising interoperability, and product upgrades are other factors attributing to the market growth over the forecast period. In addition, increasing competition amongst the major pharmaceutical companies is urging them to expand their R&D budgets, thus resulting in a greater number of clinical studies. Also, the increasing number of patent expirations is another factor contributing to the increase in the number of clinical studies for drug development and discovery. This is anticipated to propel the demand for EDC systems.